Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Breast Cancer

  Free Subscription

Articles published in Radiology

Retrieve available abstracts of 56 articles:
HTML format

Single Articles

    October 2021
  1. MANKOFF DA, Sellmyer MA
    PET of Fibroblast-Activation Protein for Breast Cancer Diagnosis and Staging.
    Radiology. 2021 Oct 12:212098. doi: 10.1148/radiol.2021212098.

  2. BACKHAUS P, Burg MC, Roll W, Buther F, et al
    Simultaneous FAPI PET/MRI Targeting the Fibroblast-Activation Protein for Breast Cancer.
    Radiology. 2021 Oct 12:204677. doi: 10.1148/radiol.2021204677.
    PubMed     Abstract available

    September 2021
  3. BAE MS, Kim HG
    Breast Cancer Risk Prediction Using Deep Learning.
    Radiology. 2021 Sep 7:211446. doi: 10.1148/radiol.2021211446.

    August 2021
  4. CHOU SS, Romanoff J, Lehman CD, Khan SA, et al
    Preoperative Breast MRI for Newly Diagnosed Ductal Carcinoma in Situ: Imaging Features and Performance in a Multicenter Setting (ECOG-ACRIN E4112 Trial).
    Radiology. 2021 Aug 3:204743. doi: 10.1148/radiol.2021204743.
    PubMed     Abstract available

    July 2021
  5. LEE SH, Ryu HS, Jang MJ, Yi A, et al
    Glandular Tissue Component and Breast Cancer Risk in Mammographically Dense Breasts at Screening Breast US.
    Radiology. 2021 Jul 20:210367. doi: 10.1148/radiol.2021210367.
    PubMed     Abstract available

  6. BAE SJ, Cha YJ, Eun NL, Ji JH, et al
    Diagnostic Accuracy of Nonmass Enhancement at Breast MRI in Predicting Tumor Involvement of the Nipple: A Prospective Study in a Single Institution.
    Radiology. 2021 Jul 13:204136. doi: 10.1148/radiol.2021204136.
    PubMed     Abstract available

  7. CHAN HP, Helvie MA
    Using Single-View Wide-Angle DBT with AI for Breast Cancer Screening.
    Radiology. 2021 Jul 6:211203. doi: 10.1148/radiol.2021211203.

  8. PINTO MC, Rodriguez-Ruiz A, Pedersen K, Hofvind S, et al
    Impact of Artificial Intelligence Decision Support Using Deep Learning on Breast Cancer Screening Interpretation with Single-View Wide-Angle Digital Breast Tomosynthesis.
    Radiology. 2021 Jul 6:204432. doi: 10.1148/radiol.2021204432.
    PubMed     Abstract available

    June 2021
  9. LEE CS, Moy L, Hughes D, Golden D, et al
    Radiologist Characteristics Associated with Interpretive Performance of Screening Mammography: A National Mammography Database (NMD) Study.
    Radiology. 2021 Jun 22:204379. doi: 10.1148/radiol.2021204379.
    PubMed     Abstract available

    MRI Screening of Women with a Personal History of Breast Cancer.
    Radiology. 2021 Jun 8:211080. doi: 10.1148/radiol.2021211080.

  11. KIM GR, Cho N, Kim SY, Han W, et al
    Interval Cancers after Negative Supplemental Screening Breast MRI Results in Women with a Personal History of Breast Cancer.
    Radiology. 2021 Jun 8:203074. doi: 10.1148/radiol.2021203074.
    PubMed     Abstract available

    May 2021
  12. CHANG JM
    MRI Screening Interval in Women with a History of Breast Cancer.
    Radiology. 2021 May 25:210836. doi: 10.1148/radiol.2021210836.

  13. PARK VY, Kim MJ, Kim GR, Yoon JH, et al
    Outcomes Following Negative Screening MRI Results in Korean Women with a Personal History of Breast Cancer: Implications for the Next MRI Interval.
    Radiology. 2021 May 25:204217. doi: 10.1148/radiol.2021204217.
    PubMed     Abstract available

  14. MOY L, Gao Y
    Digital Mammography Is Similar to Screen-Film Mammography for Women with Personal History of Breast Cancer.
    Radiology. 2021 May 18:210930. doi: 10.1148/radiol.2021210930.

  15. LEE JM, Ichikawa LE, Wernli KJ, Bowles E, et al
    Digital Mammography and Breast Tomosynthesis Performance in Women with a Personal History of Breast Cancer, 2007-2016.
    Radiology. 2021 May 18:204581. doi: 10.1148/radiol.2021204581.
    PubMed     Abstract available

    Interval Breast Cancer after Digital Breast Tomosynthesis-based Screening: A Glimmer of Hope.
    Radiology. 2021 May 11:210179. doi: 10.1148/radiol.2021210179.

  17. HOFVIND S, Moshina N, Holen AS, Danielsen AS, et al
    Interval and Subsequent Round Breast Cancer in a Randomized Controlled Trial Comparing Digital Breast Tomosynthesis and Digital Mammography Screening.
    Radiology. 2021 May 11:203936. doi: 10.1148/radiol.2021203936.
    PubMed     Abstract available

  18. RAYA-POVEDANO JL, Romero-Martin S, Elias-Cabot E, Gubern-Merida A, et al
    AI-based Strategies to Reduce Workload in Breast Cancer Screening with Mammography and Tomosynthesis: A Retrospective Evaluation.
    Radiology. 2021 May 4:203555. doi: 10.1148/radiol.2021203555.
    PubMed     Abstract available

    April 2021
  19. BYON JH, Park YV, Yoon JH, Moon HJ, et al
    Added Value of MRI for Invasive Breast Cancer including the Entire Axilla for Evaluation of High-Level or Advanced Axillary Lymph Node Metastasis in the Post-ACOSOG Z0011 Trial Era.
    Radiology. 2021 Apr 27:202683. doi: 10.1148/radiol.2021202683.
    PubMed     Abstract available

  20. PARK AR, Chae EY, Cha JH, Shin HJ, et al
    Preoperative Breast MRI in Women 35 Years of Age and Younger with Breast Cancer: Benefits in Surgical Outcomes by Using Propensity Score Analysis.
    Radiology. 2021 Apr 20:204124. doi: 10.1148/radiol.2021204124.
    PubMed     Abstract available

  21. MANN RM
    Tomosynthesis Is Taking Small Steps to Become the Standard for Breast Cancer Screening.
    Radiology. 2021 Apr 6:210153. doi: 10.1148/radiol.2021210153.

  22. JOHNSON K, Lang K, Ikeda DM, Akesson A, et al
    Interval Breast Cancer Rates and Tumor Characteristics in the Prospective Population-based Malmo Breast Tomosynthesis Screening Trial.
    Radiology. 2021 Apr 6:204106. doi: 10.1148/radiol.2021204106.
    PubMed     Abstract available

    March 2021
  23. FEIG SA
    Influence of Patient Participation on Decreased Mortality from Screening Mammography.
    Radiology. 2021 Mar 30:210226. doi: 10.1148/radiol.2021210226.

  24. LEE CS, Berg JM, Berg WA
    Cancer Yield Exceeds 2% for BI-RADS 3 Probably Benign Findings in Women Older Than 60 Years in the National Mammography Database.
    Radiology. 2021 Mar 30:204031. doi: 10.1148/radiol.2021204031.
    PubMed     Abstract available

  25. KIM SY, Cho N, Choi Y, Lee SH, et al
    Factors Affecting Pathologic Complete Response Following Neoadjuvant Chemotherapy in Breast Cancer: Development and Validation of a Predictive Nomogram.
    Radiology. 2021 Mar 23:203871. doi: 10.1148/radiol.2021203871.
    PubMed     Abstract available

  26. MOY L, Gao Y
    Supplemental MRI in Extremely Dense Breasts: Sharp Reduction in False-Positive Rate in the Second Screening Round of the DENSE Trial.
    Radiology. 2021 Mar 16:210265. doi: 10.1148/radiol.2021210265.

  27. VEENHUIZEN SGA, de Lange SV, Bakker MF, Pijnappel RM, et al
    Supplemental Breast MRI for Women with Extremely Dense Breasts: Results of the Second Screening Round of the DENSE Trial.
    Radiology. 2021 Mar 16:203633. doi: 10.1148/radiol.2021203633.
    PubMed     Abstract available

  28. DUFFY SW, Tabar L, Yen AM, Dean PB, et al
    Beneficial Effect of Consecutive Screening Mammography Examinations on Mortality from Breast Cancer: A Prospective Study.
    Radiology. 2021 Mar 2:203935. doi: 10.1148/radiol.2021203935.
    PubMed     Abstract available

  29. JOCHELSON MS, Lobbes MBI
    Contrast-enhanced Mammography: State of the Art.
    Radiology. 2021 Mar 2:201948. doi: 10.1148/radiol.2021201948.
    PubMed     Abstract available

    February 2021
  30. OZUTEMIZ C, Krystosek LA, Church AL, Chauhan A, et al
    Lymphadenopathy in COVID-19 Vaccine Recipients: Diagnostic Dilemma in Oncology Patients.
    Radiology. 2021 Feb 24:210275. doi: 10.1148/radiol.2021210275.
    PubMed     Abstract available

  31. KWON MR, Choi JS, Won H, Ko EY, et al
    Breast Cancer Screening with Abbreviated Breast MRI: 3-year Outcome Analysis.
    Radiology. 2021 Feb 23:202927. doi: 10.1148/radiol.2021202927.
    PubMed     Abstract available

  32. ZARIC O, Farr A, Minarikova L, Lachner S, et al
    Tissue Sodium Concentration Quantification at 7.0-T MRI as an Early Marker for Chemotherapy Response in Breast Cancer: A Feasibility Study.
    Radiology. 2021 Feb 16:201600. doi: 10.1148/radiol.2021201600.
    PubMed     Abstract available

  33. HARADA TL, Uematsu T, Nakashima K, Kawabata T, et al
    Evaluation of Breast Edema Findings at T2-weighted Breast MRI Is Useful for Diagnosing Occult Inflammatory Breast Cancer and Can Predict Prognosis after Neoadjuvant Chemotherapy.
    Radiology. 2021 Feb 9:202604. doi: 10.1148/radiol.2021202604.
    PubMed     Abstract available

  34. HENDRICK RE, Helvie MA, Monticciolo DL
    Breast Cancer Mortality Rates Have Stopped Declining in U.S. Women Younger than 40 Years.
    Radiology. 2021 Feb 9:203476. doi: 10.1148/radiol.2021203476.
    PubMed     Abstract available

    January 2021
  35. RAHBAR H
    Closing the Chapter on Supplemental Breast Cancer Screening with US.
    Radiology. 2021 Jan 12:204334. doi: 10.1148/radiol.2021204334.

  36. YI A, Jang MJ, Yim D, Kwon BR, et al
    Addition of Screening Breast US to Digital Mammography and Digital Breast Tomosynthesis for Breast Cancer Screening in Women at Average Risk.
    Radiology. 2021 Jan 12:203134. doi: 10.1148/radiol.2021203134.
    PubMed     Abstract available

  37. BAE MS
    Sustainable Benefits of Digital Breast Tomosynthesis Screening.
    Radiology. 2021;298:58-59.

  38. EL KHOURY M, Maietta A, Tran A, Trop I, et al
    Case 285: Primary Breast Lymphoma.
    Radiology. 2021;298:231-236.
    PubMed     Abstract available

    December 2020
  39. BAHL M, Mercaldo S, McCarthy AM, Lehman CD, et al
    Imaging Surveillance of Breast Cancer Survivors with Digital Mammography versus Digital Breast Tomosynthesis.
    Radiology. 2020 Dec 22:201854. doi: 10.1148/radiol.2020201854.
    PubMed     Abstract available

  40. HOOLEY R, Butler R
    Digital Breast Tomosynthesis May Not Provide Optimal Surveillance of Breast Cancer Survivors.
    Radiology. 2020 Dec 22:204219. doi: 10.1148/radiol.2020204219.

  41. DURAND MA, Friedewald SM, Plecha DM, Copit DS, et al
    False-Negative Rates of Breast Cancer Screening with and without Digital Breast Tomosynthesis.
    Radiology. 2020 Dec 1:202858. doi: 10.1148/radiol.2020202858.
    PubMed     Abstract available

  42. PUJARA AC, Joe AI, Patterson SK, Neal CH, et al
    Digital Breast Tomosynthesis Slab Thickness: Impact on Reader Performance and Interpretation Time.
    Radiology. 2020;297:534-542.
    PubMed     Abstract available

    High-Quality Mammography: A Step Forward for Women's Health.
    Radiology. 2020 Dec 1:204087. doi: 10.1148/radiol.2020204087.

    November 2020
  44. MCDONALD ES, Romanoff J, Rahbar H, Kitsch AE, et al
    Mean Apparent Diffusion Coefficient Is a Sufficient Conventional Diffusion-weighted MRI Metric to Improve Breast MRI Diagnostic Performance: Results from the ECOG-ACRIN Cancer Research Group A6702 Diffusion Imaging Trial.
    Radiology. 2020 Nov 17:202465. doi: 10.1148/radiol.2020202465.
    PubMed     Abstract available

  45. CAUMO F, Montemezzi S, Romanucci G, Brunelli S, et al
    Repeat Screening Outcomes with Digital Breast Tomosynthesis Plus Synthetic Mammography for Breast Cancer Detection: Results from the Prospective Verona Pilot Study.
    Radiology. 2020 Nov 10:201246. doi: 10.1148/radiol.2020201246.
    PubMed     Abstract available

    October 2020
  46. KOSMIN M, Padhani AR, Gogbashian A, Woolf D, et al
    Comparison of Whole-Body MRI, CT, and Bone Scintigraphy for Response Evaluation of Cancer Therapeutics in Metastatic Breast Cancer to Bone.
    Radiology. 2020 Oct 20:192683. doi: 10.1148/radiol.2020192683.
    PubMed     Abstract available

  47. JIANG Y, Edwards AV, Newstead GM
    Artificial Intelligence Applied to Breast MRI for Improved Diagnosis.
    Radiology. 2020 Oct 20:200292. doi: 10.1148/radiol.2020200292.
    PubMed     Abstract available

  48. ZUCKERMAN SP, Sprague BL, Weaver DL, Herschorn SD, et al
    Multicenter Evaluation of Breast Cancer Screening with Digital Breast Tomosynthesis in Combination with Synthetic versus Digital Mammography.
    Radiology. 2020 Oct 13:200240. doi: 10.1148/radiol.2020200240.
    PubMed     Abstract available

  49. LANG K
    Mounting Evidence for Synthetic Mammography in Breast Cancer Screening.
    Radiology. 2020 Oct 13:203716. doi: 10.1148/radiol.2020203716.

    September 2020
  50. MOSHINA N, Aase HS, Danielsen AS, Haldorsen IS, et al
    Comparing Screening Outcomes for Digital Breast Tomosynthesis and Digital Mammography by Automated Breast Density in a Randomized Controlled Trial: Results from the To-Be Trial.
    Radiology. 2020 Sep 15:201150. doi: 10.1148/radiol.2020201150.
    PubMed     Abstract available

  51. CHUNG M, Hayward JH, Woodard GA, Knobel A, et al
    US as the Primary Imaging Modality in the Evaluation of Palpable Breast Masses in Breastfeeding Women, Including Those of Advanced Maternal Age.
    Radiology. 2020 Sep 1:201036. doi: 10.1148/radiol.2020201036.
    PubMed     Abstract available

    August 2020
  52. MCKAY JA, Church AL, Rubin N, Emory TH, et al
    A Comparison of Methods for High-Spatial-Resolution Diffusion-weighted Imaging in Breast MRI.
    Radiology. 2020 Aug 25:200221. doi: 10.1148/radiol.2020200221.
    PubMed     Abstract available

    July 2020
  53. BROWN AL, Wahab RA
    MRI of Primary Angiosarcoma of the Breast.
    Radiology. 2020 Jul 28:201377. doi: 10.1148/radiol.2020201377.

  54. SALIM M, Dembrower K, Eklund M, Lindholm P, et al
    Range of Radiologist Performance in a Population-based Screening Cohort of 1 Million Digital Mammography Examinations.
    Radiology. 2020 Jul 28:192212. doi: 10.1148/radiol.2020192212.
    PubMed     Abstract available

  55. MOY L
    BI-RADS Category 3 Is a Safe and Effective Alternative to Biopsy or Surgical Excision.
    Radiology. 2020;296:42-43.

    May 2020
  56. BERG WA, Berg JM, Sickles EA, Burnside ES, et al
    Cancer Yield and Patterns of Follow-up for BI-RADS Category 3 after Screening Mammography Recall in the National Mammography Database.
    Radiology. 2020 May 19:192641. doi: 10.1148/radiol.2020192641.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.